BR9701404A - Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol - Google Patents

Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol

Info

Publication number
BR9701404A
BR9701404A BR9701404A BR9701404A BR9701404A BR 9701404 A BR9701404 A BR 9701404A BR 9701404 A BR9701404 A BR 9701404A BR 9701404 A BR9701404 A BR 9701404A BR 9701404 A BR9701404 A BR 9701404A
Authority
BR
Brazil
Prior art keywords
trisdehydro
cholecal
ciferol
dihydroxy
derivatives
Prior art date
Application number
BR9701404A
Other languages
English (en)
Inventor
Jerome Anthony Lacobelli
Milan Radoje Uskokovic
Bernard Michael Hennessy
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9701404A publication Critical patent/BR9701404A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
BR9701404A 1996-03-21 1997-03-20 Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol BR9701404A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1380996P 1996-03-21 1996-03-21

Publications (1)

Publication Number Publication Date
BR9701404A true BR9701404A (pt) 1998-11-03

Family

ID=21761865

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9701404A BR9701404A (pt) 1996-03-21 1997-03-20 Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol

Country Status (30)

Country Link
EP (1) EP0796843B1 (pt)
JP (1) JP2801587B2 (pt)
KR (1) KR100240541B1 (pt)
CN (1) CN1110477C (pt)
AR (1) AR006315A1 (pt)
AT (1) ATE240941T1 (pt)
AU (1) AU708679B2 (pt)
BR (1) BR9701404A (pt)
CA (1) CA2199893C (pt)
CO (1) CO4820396A1 (pt)
CZ (1) CZ85897A3 (pt)
DE (1) DE69722064T2 (pt)
DK (1) DK0796843T3 (pt)
ES (1) ES2198512T3 (pt)
HR (1) HRP970162A2 (pt)
HU (1) HUP9700609A3 (pt)
ID (1) ID16285A (pt)
IL (1) IL120469A0 (pt)
MA (1) MA26423A1 (pt)
MX (1) MX9702139A (pt)
NO (1) NO971217L (pt)
NZ (1) NZ314424A (pt)
PE (1) PE42998A1 (pt)
PL (1) PL319070A1 (pt)
PT (1) PT796843E (pt)
SG (1) SG70589A1 (pt)
TR (1) TR199700219A3 (pt)
TW (1) TW444001B (pt)
YU (1) YU10397A (pt)
ZA (1) ZA972302B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
KR101285720B1 (ko) * 2012-03-02 2013-07-19 주식회사 유니크메디케어 여드름 개선용 조성물
KR102493627B1 (ko) 2015-11-26 2023-01-31 코웨이 주식회사 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
DK0398217T3 (da) * 1989-05-18 1994-02-14 Hoffmann La Roche Dehydrocholecalciferolderivater

Also Published As

Publication number Publication date
CA2199893C (en) 2008-02-05
YU10397A (sh) 1999-07-28
CZ85897A3 (cs) 1998-04-15
EP0796843A2 (en) 1997-09-24
CN1172793A (zh) 1998-02-11
AR006315A1 (es) 1999-08-25
DE69722064D1 (de) 2003-06-26
KR970065495A (ko) 1997-10-13
CA2199893A1 (en) 1997-09-21
SG70589A1 (en) 2000-02-22
TR199700219A2 (xx) 1997-10-21
TW444001B (en) 2001-07-01
PL319070A1 (en) 1997-09-29
TR199700219A3 (tr) 1997-10-21
IL120469A0 (en) 1997-07-13
ZA972302B (en) 1997-09-22
CN1110477C (zh) 2003-06-04
EP0796843B1 (en) 2003-05-21
HU9700609D0 (en) 1997-05-28
JPH107651A (ja) 1998-01-13
AU708679B2 (en) 1999-08-12
MA26423A1 (fr) 2004-12-20
ATE240941T1 (de) 2003-06-15
KR100240541B1 (ko) 2000-01-15
MX9702139A (es) 1998-04-30
JP2801587B2 (ja) 1998-09-21
ID16285A (id) 1997-09-18
AU1513597A (en) 1997-09-25
DE69722064T2 (de) 2004-04-08
DK0796843T3 (da) 2003-09-15
CO4820396A1 (es) 1999-07-28
ES2198512T3 (es) 2004-02-01
PE42998A1 (es) 1998-08-11
HRP970162A2 (en) 1998-04-30
PT796843E (pt) 2003-09-30
EP0796843A3 (en) 1999-04-14
NO971217D0 (no) 1997-03-17
NO971217L (no) 1997-09-22
HUP9700609A3 (en) 1999-03-01
NZ314424A (en) 1998-07-28
HUP9700609A2 (hu) 1998-07-28

Similar Documents

Publication Publication Date Title
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
PT901474E (pt) Derivados de aril-pirimidina.
PT934320E (pt) Derivados de naftiridina
BR9708386A (pt) Derivados de 6-fenilpiridil-2-amina
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
DE69718771T2 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
PT922050E (pt) Derivados de 3-descladinose-2,3-anidroeritromicina
MA26503A1 (fr) Derives de 5'-desoxy-cytidine.
BR9709251A (pt) Derivados de 2,4-diaminopirimidina
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
PT931087E (pt) Novos derivados de piranosido
DE69714358D1 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
PT906279E (pt) Derivados de pirrol
MA26440A1 (fr) Derives de n-benzylazolium
BR9701404A (pt) Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol
BR9708310A (pt) Derivados de 2-tioxotetrahidropirimidin-4-ona
BR9706980A (pt) Derivados de isooxacefem
BR9510036A (pt) Derivados de 1,3,4-oxadiazina
BR9708948A (pt) 1,3 - Benzodioxois substituídos
TR199700927A3 (tr) N-Benzilazolyum türevleri.

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1838 DE 28/03/2006.